Another study proved that increased ZEB1‐AS1 contributes to enhanced bone metastasis in hepatocellular carcinoma via miR‐302b/EGFR/PI3K/AKT signaling pathway.17 The gene discussed is EGFR; the disease is hepatocellular carcinoma.